Banner2 Banner3 Latest News View Index 10.06.2022 Santen Announces Health Canada Approval for Cationorm® Plus to Relieve the Symptoms of Dry Eye and Ocular Allergy 09.26.2022 Santen and UBE Received FDA Approval for OMLONTI® (Omidenepag Isopropyl Ophthalmic Solution) 0.002% for the Reduction of Elevated Intraocular Pressure in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension 05.08.2022 Santen Reports Consolidated Results for Fiscal 2021 05.02.2022 Santen’s Verkazia® (Cyclosporine Ophthalmic
Santen is a Social Innovator that mobilizes key global technologies and players to resolve eye-related problems worldwide. Aiming to help people everywhere achieve happiness through vision, Santen has developed and is delivering eyecare solutions to tens of millions patients in more than 60 countries.
Links to santenusa.com (40)
santen.euSanten Europe - Eye health pharmaceutical company
Santen Europe - Eye health pharmaceutical company